Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|March 22, 2017
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapyLieve Brochez, Ines Chevolet, Vibeke KruseActa Clinica Belgica|March 23, 2021
Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the keyMichael Saerens, Vibeke Kruse, Willem LybaertTrends in Endocrinology and Metabolism: TEM|July 3, 2017
The Significance of Epidermal Lipid Metabolism in Whole-Body PhysiologyVibeke Kruse, Ditte Neess, Nils J FærgemanCase Reports in Dermatology|September 7, 2018
Psoriasis Vulgaris Exacerbation during Treatment with a PD-1 Checkpoint Inhibitor: Case Report and Literature ReviewMarlies De Bock, Eva Hulstaert, Vibeke Kruse, et al.European Journal of Cancer Care|October 5, 2018
Throughput efficiency and service quality after process redesign at a cancer day care unit: Two sides of the coin?Kaat De Pourcq, Paul Gemmel, Jeroen Trybou, et al.Cureus|September 21, 2022
Exploring a New Entity of Single-Agent Pembrolizumab-Associated HypophysitisEric Balti, Sarah Verhaeghe, Vibeke Kruse, et al.Cureus|March 22, 2024
Correction: Exploring a New Entity of Single-Agent Pembrolizumab-Associated HypophysitisEric Balti, Sarah Verhaeghe, Vibeke Kruse, et al.Endocrine|February 21, 2014
Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reportsJoke Marlier, Veronique Cocquyt, Lieve Brochez, et al.Clinical Nuclear Medicine|March 30, 2021
Spatiotemporal Evolution of Radiation Myositis on 18F-FDG PET/CT Following Hypofractionated Radiotherapy of Intramuscular Melanoma MetastasesMathieu Spaas, Bliede Van den Broeck, David Creytens, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2012
Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumoursChristophe Van de Wiele, Vibeke Kruse, Peter Smeets, et al.Pageof 4